Research progress on perioperative anticoagulants in perioperative period of free flap transplantation.
10.7507/1002-1892.202507042
- Author:
Haokun QIN
1
;
Chengliang DENG
1
Author Information
1. Department of Burn and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi Guizhou, 563003, P. R. China.
- Publication Type:English Abstract
- Keywords:
Free flap;
anticoagulants;
complications;
perioperative period;
thrombosis
- MeSH:
Humans;
Anticoagulants/therapeutic use*;
Free Tissue Flaps/blood supply*;
Thrombosis/prevention & control*;
Perioperative Care/methods*;
Heparin/therapeutic use*;
Heparin, Low-Molecular-Weight/administration & dosage*;
Perioperative Period;
Aspirin/therapeutic use*
- From:
Chinese Journal of Reparative and Reconstructive Surgery
2025;39(11):1474-1484
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To review current status of clinical application and research progress of different anticoagulants in perioperative period of free flap transplantation.
METHODS:A comprehensive review of recent relevant literature was conducted, focusing on clinical research concerning the application of anticoagulants in the perioperative period of free flap transplantation. The administration route, timing, dosage selection, effectiveness, and safety of commonly used and novel anticoagulants were summarized.
RESULTS:At present, the anticoagulants mainly used in the perioperative period of free flap transplantation include drugs for venous thrombosis prophylaxis, drugs for arterial thrombosis prophylaxis, and physical/colloidal anticoagulants, etc. The administration strategies can be classified into two major categories: single-agent anticoagulation and combined anticoagulation. Single-agent anticoagulation mainly includes unfractionated heparin, low-molecular-weight heparin, aspirin, and novel anticoagulants. Combined anticoagulation is commonly a synergistic anticoagulation regimen dominated by heparin drugs, combined with aspirin, different antiplatelet drugs, and expansion agents. Studies indicate that perioperative anticoagulant administration can effectively reduce the risk of thrombosis in free flaps and improve the overall flap survival rate. However, significant differences exist in the impact of drug types, administration routes, initiation timing, and dosage intensity on efficacy and bleeding risk. A unified, standardized application protocol has not yet been established. In addition, there has been a growing number of studies on novel anticoagulant drugs. However, their superiority and optimal application strategies in the field of free flap transplantation still necessitate more high-quality evidence.
CONCLUSION:Perioperative anticoagulation therapy represents one of the key strategies for improving the survival rate of free flaps. However, there is still a lack of high-level evidence to establish a standard protocol. Future research should focus on the optimization of individualized anticoagulation strategies, the validation of the effectiveness of new anticoagulants, and the exploration of the advantages of different anticoagulation strategies. At the same time, attention should be paid to balancing anticoagulation and bleeding risks to promote the standardization of clinical practice and the improvement of treatment safety.
